Back to User profile » Dr Jie-Pin Li

Papers published by Dr Jie-Pin Li:


Endoplasmic Reticulum Membrane Protein Complex Regulates Cancer Stem Cells and is Associated with Sorafenib Resistance in Hepatocellular Carcinoma

Liu YJ, Li JX, Li JP, Hu YD, Ma ZB, Huang W, Liu SL, Zou X

Journal of Hepatocellular Carcinoma 2024, 11:1519-1539

Published Date: 9 August 2024

An Analysis Regarding the Association Between the Nuclear Pore Complex (NPC) and Hepatocellular Carcinoma (HCC)

Huang P, Hu YD, Liu YJ, Li JP, Zhang YH

Journal of Hepatocellular Carcinoma 2023, 10:959-978

Published Date: 22 June 2023

An Analysis Regarding the Association Between Proteasome (PSM) and Hepatocellular Carcinoma (HCC)

Huang W, Mei J, Liu YJ, Li JP, Zou X, Qian XP, Zhang Y

Journal of Hepatocellular Carcinoma 2023, 10:497-515

Published Date: 30 March 2023

Nidogen-2 (NID2) is a Key Factor in Collagen Causing Poor Response to Immunotherapy in Melanoma

Sha Y, Mao AQ, Liu YJ, Li JP, Gong YT, Xiao D, Huang J, Gao YW, Wu MY, Shen H

Pharmacogenomics and Personalized Medicine 2023, 16:153-172

Published Date: 4 March 2023

Identification and Validation in a Novel Classification of Helicase Patterns for the Prediction of Tumor Proliferation and Prognosis

Yin Y, Xu ZY, Liu YJ, Huang W, Zhang Q, Li JP, Zou X

Journal of Hepatocellular Carcinoma 2022, 9:885-900

Published Date: 27 August 2022

USP35 is a Potential Immunosuppressive Factor in Skin Cutaneous Melanoma

Zhang Q, Liu YJ, Li JP, Zeng SH, Shen H, Han M, Guo S, Liu SL, Zou X

Journal of Inflammation Research 2022, 15:3065-3082

Published Date: 24 May 2022

An Analysis Regarding the Association Between Connexins and Colorectal Cancer (CRC) Tumor Microenvironment

Liu YJ, Han M, Li JP, Zeng SH, Ye QW, Yin ZH, Liu SL, Zou X

Journal of Inflammation Research 2022, 15:2461-2476

Published Date: 15 April 2022

DNTTIP2 Expression is Associated with Macrophage Infiltration and Malignant Characteristics in Low-Grade Glioma

Liu YJ, Zeng SH, Qian WH, Tao MX, Zhu YY, Li JP

Pharmacogenomics and Personalized Medicine 2022, 15:261-275

Published Date: 24 March 2022

DZIP1 Expression as a Prognostic Marker in Gastric Cancer: A Bioinformatics-Based Analysis

Liu YJ, Li JP, Zeng SH, Han M, Liu SL, Zou X

Pharmacogenomics and Personalized Medicine 2021, 14:1151-1168

Published Date: 16 September 2021

FSTL3 is a Prognostic Biomarker in Gastric Cancer and is Correlated with M2 Macrophage Infiltration

Liu YJ, Li JP, Zhang Y, Nie MJ, Zhang YH, Liu SL, Zou X

OncoTargets and Therapy 2021, 14:4099-4117

Published Date: 6 July 2021